Target intelligence / Profile preview

RNA, U6 small nuclear 883, pseudogene (RNU6-883P)

Target
RNU6-883P
Molecular classification
Non-coding RNA pseudogene
01

Overview

RNU6-883P is classified as a pseudogene derived from the U6 small nuclear RNA gene family. U6 snRNA itself is an essential non-coding RNA component of the spliceosome, which is involved in the removal of introns from pre-mRNA during RNA splicing in eukaryotic nuclei[5]. However, RNU6-883P is a non-functional "pseudogene" copy of this snRNA, likely formed through retrotransposon activity and not thought to be transcribed into a functional RNA molecule[7]. Pseudogenes like RNU6-883P are common in the human genome and, while most are non-functional remnants, some can participate in regulatory processes or serve as evolutionary markers, but no direct evidence for such functions specific to RNU6-883P exists[2][7][5]. This is not a receptor, enzyme, or any classical therapeutic target; it is a non-coding RNA pseudogene. There is no evidence that RNU6-883P has a direct biological function, disease relevance, or drug interactions. Pseudogenes can have rare regulatory roles but this is not generally established for the vast majority, including this one[2][7]. The name is sometimes misspelled or confused with similar-numbered U6 snRNA pseudogenes (such as RNU6-833P or RNU6-83P)[1][4], but the core category and function are unchanged. In conclusion, RNU6-883P is a non-coding RNA pseudogene unrelated to therapeutic target classes such as receptors or enzymes, and is not generally relevant as a drug target, biomarker, or disease gene in current biomedical knowledge.

Other names
RNU6-883PU6 snRNA pseudogene 883U6 small nuclear RNA pseudogene 883

Beyond the preview

Go deeper on RNA, U6 small nuclear 883, pseudogene (RNU6-883P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 883, pseudogene (RNU6-883P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call